This section hosts guidelines, manuals and toolkits to strengthen public health practice.
The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to determine whether revisions to the fifth edition of the Medical Eligibility Criteria for contraceptive use (MEC) were needed. The issue was deemed critical in the context of women at a high lifetime risk of acquiring HIV alongside the importance of hormonal contraception in offering women and adolescent girls’ a choice and in reducing their risk of unintended pregnancy, a common threat to the health, well-being and lives of women and adolescent girls. The GDG, consisting of 28 participants from 19 countries, made recommendations on contraceptive methods used by women at high risk of HIV. These document outlines the recommendations which may be useful for policy makers. Click here to read the recommendations.